Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2013 by Yonsei University.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Yonsei University
Information provided by (Responsible Party):
jong bum Choi, Yonsei University
ClinicalTrials.gov Identifier:
NCT01601925
First received: May 3, 2012
Last updated: January 23, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Stellate ganglion block targets are C6 transverse process or C7 transverse process in anterior paratracheal approach which is most popular method. Cricoid cartilage is known that it is located at C6 level in supine neutral position of the neck. But stellate ganglion block is performed in supine extended position of the neck. So cricoid cartilage will move up to cephalad direction and pain doctors should find C6 or C7 transverse process at lower neck area than cricoid cartilage.
| Condition | Intervention |
|---|---|
|
Herpes Zoster CRPS |
Other: supine extended position of the neck |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block |
Further study details as provided by Yonsei University:
Primary Outcome Measures:
- the distances from cricoid cartilage to C6, C7 transverse process in supine neutral and extended position of the neck [ Time Frame: up to 1 week ] [ Designated as safety issue: No ]The distances from cricoid cartilage to C6, C7 transverse process will be measured in supine neural position and extended position of the neck up to 1 week after agreement to enroll
Secondary Outcome Measures:
- the sexual difference in the distances from cricoid cartilage to C6, C7 transverse process in supine neutral or extended position of the neck [ Time Frame: up to 1 week ] [ Designated as safety issue: No ]The sexual difference in the distances from cricoid cartilage to C6,C7 transverse process will be measured in supine neural position and extended position of the neck up to 1 week after agreement to enroll
| Estimated Enrollment: | 42 |
| Study Start Date: | January 2012 |
| Estimated Study Completion Date: | July 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: neck extended group
We measured the distances from cricoid cartilage to C6 or C7 transverse process in supine neutral and extended position of the neck.
|
Other: supine extended position of the neck
we measure the distances from cricoid cartilage to C6 or C7 transverse process in supine neutral and extended position of the neck
|
Eligibility| Ages Eligible for Study: | 20 Years and older (Adult, Senior) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- adults above age of 20 reserved for musculoskeletal ultrasonography
Exclusion Criteria:
- past history of neck surgery
- the limitation of neck motion due to rheumatoid arthritis, et al.
- severe neck pain
- inability to communicate or read or write
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01601925
Please refer to this study by its ClinicalTrials.gov identifier: NCT01601925
Contacts
| Contact: Jong B Choi | 82-2-2019-6093 | romeojb@naver.com |
Locations
| Korea, Republic of | |
| Gangnam Severance hospital | Recruiting |
| Seoul, Korea, Republic of | |
Sponsors and Collaborators
Yonsei University
Investigators
| Study Director: | Jong B Choi | Yonsei University |
More Information
| Responsible Party: | jong bum Choi, Yonsei University College of Medicine, Yonsei University |
| ClinicalTrials.gov Identifier: | NCT01601925 History of Changes |
| Other Study ID Numbers: | 3-2011-0231 |
| Study First Received: | May 3, 2012 |
| Last Updated: | January 23, 2013 |
| Health Authority: | Korea: Food and Drug Administration |
Additional relevant MeSH terms:
|
Herpes Zoster Herpesviridae Infections DNA Virus Infections Virus Diseases |
ClinicalTrials.gov processed this record on September 27, 2016